Welcome to the Grice Lab
Welcome to the Grice Laboratory in the Department of Dermatology at the Perelman School of Medicine, University of Pennsylvania!
Our research integrates dermatology, microbiology, microbiome, omics, bioinformatics, and immunology to examine host-microbe/microbiome interactions of the skin in health and disease.
We are an interdisciplinary and highly collaborative team of post-doctoral fellows, graduate students, and technical staff.
We invite you to explore our website to learn more about our research program and its members.
Grice Lab's latest news, events, and announcements
Double celebration alert!
On International Women's Day (8M) we commemorate women's fight for equality and we recognize with a proud shout-out our wonderful postdocs Dr. Sofía Murga-Garrido and Dr. Deborah Minzaghi for becoming part of the 2025 DF Research Award Recipients!
We congratulate the fabulous Dr. Tori Lovins and her collaborators for the publication of their work "Staphylococcus aureus promotes strain-dependent immunopathology during cutaneous leishmaniasis through induction of IL-1β" at Cell Reports!
In The News
-
Sponsored: 64% off Code Black Drone with HD Camera
Wednesday, May 4, 2016
Our #1 Best-Selling Drone--Meet the Dark Night of the Sky!
-
Yelp Pretty Good at Helping Patients Pick Hospitals
Tuesday, April 5, 2016
PhillyMag's Biz Philly blog reported on new Penn research suggesting Yelp offers hospital assessments that line up closely with more formal, government-approved appraisals, and may even be more comprehensive in its outlook. Authors Raina M. Merchant, MD, an assistant professor of Emergency Medicine and director of the Penn Social Media and Health Innovation Lab, and Benjamin L. Ranard, a junior fellow at the Penn Social Media and Health Innovation Lab, are quoted in the story.
-
The Highs and the Lows: End-of-Life Care in the U.S.
Tuesday, April 5, 2016
An article from Medical Ethics Advisor says that according to a recent study comparing the site of death, healthcare utilization, and hospital expenditures for terminally ill cancer patients in seven developed countries, ICU admissions are far more common in the United States than other countries, yet the U.S. has the lowest proportion of in-hospital deaths. Justin E. Bekelman, MD, associate professor in the departments of Radiation Oncology and Medical Ethics and Health Policy, is quoted.